Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
01/12/21 | 8-K | Current report filing |
![]() ![]() |
24 | |
01/05/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
13 | |
01/05/21 | 8-K | Current report filing |
![]() ![]() |
27 | |
01/04/21 | EFFECT | Notice of Effectiveness |
![]() ![]() |
1 | |
01/04/21 | 4 | Lederman Seth |
![]() ![]() |
2 | |
12/30/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
![]() ![]() |
1 | |
12/23/20 | UPLOAD | SEC-generated letter |
![]() |
1 | |
12/23/20 | 8-K | Current report filing |
![]() ![]() |
26 | |
12/22/20 | 8-K | Current report filing |
![]() ![]() |
4 | |
12/21/20 | 8-K | Current report filing |
![]() ![]() |
7 |